Clinical Trial Update: A Study to Evaluate the Safety, Efficacy, and Pharmacodynamics of PLL001 in ALS Patients [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial to evaluate the safety, efficacy, and pharmacodynamics of PLL001 in patients with Amyotrophic Lateral Sclerosis (ALS). The study stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• PLL001

Snippet

Sponsor: PLL TX AUSTRALIA PTY LTD | Conditions: Amyotrophic Lateral Sclerosis, ALS | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING